PURPOSE: A high lactate content in malignant head and neck cancer (Head and neck squamous cell carcinomas, HNSCC) is associated with a higher risk of metastatic spread and lower overall patient survival. However, until present, the underlying mechanisms are not clearly understood. Here, a systematic comparison of glucose metabolism in HNSCC and homologous normal tissue is presented for the first time. METHODS: The concentrations of glucose, lactate and ATP were measured in cryobiopsies of 29 human HNSCC and of 9 normal mucosa using bioluminescence imaging. The protein expression of lactate dehydrogenase (LDH) was analyzed by Western blotting. RESULTS: Tumors own a higher content of lactate and LDH in comparison with normal tissues. However, within the tumor group, the grade of LDH expression shows substantially strong variation and overlap with normal values. Furthermore, LDH expression was not correlated with tumor lactate content. Investigating a small subpopulation, patients with a short-term survival had significantly higher tumor lactate levels compared to patients with long-term survival. CONCLUSIONS: The data provide clear evidence of an enhanced glycolysis in tumors compared to normal tissue. This may partially but not completely attributable to an elevated expression of LDH. High tumor lactate levels may be predictive for restricted patient survival. In conclusion, lactate measurements, for example non-invasively with MRT, should be advanced for use in clinical routine as a supportive tool for tumor diagnosis and prognosis.
PURPOSE: A high lactate content in malignant head and neck cancer (Head and neck squamous cell carcinomas, HNSCC) is associated with a higher risk of metastatic spread and lower overall patient survival. However, until present, the underlying mechanisms are not clearly understood. Here, a systematic comparison of glucose metabolism in HNSCC and homologous normal tissue is presented for the first time. METHODS: The concentrations of glucose, lactate and ATP were measured in cryobiopsies of 29 human HNSCC and of 9 normal mucosa using bioluminescence imaging. The protein expression of lactate dehydrogenase (LDH) was analyzed by Western blotting. RESULTS:Tumors own a higher content of lactate and LDH in comparison with normal tissues. However, within the tumor group, the grade of LDH expression shows substantially strong variation and overlap with normal values. Furthermore, LDH expression was not correlated with tumorlactate content. Investigating a small subpopulation, patients with a short-term survival had significantly higher tumorlactate levels compared to patients with long-term survival. CONCLUSIONS: The data provide clear evidence of an enhanced glycolysis in tumors compared to normal tissue. This may partially but not completely attributable to an elevated expression of LDH. High tumorlactate levels may be predictive for restricted patient survival. In conclusion, lactate measurements, for example non-invasively with MRT, should be advanced for use in clinical routine as a supportive tool for tumor diagnosis and prognosis.
Authors: Jennifer S Isaacs; Yun Jin Jung; David R Mole; Sunmin Lee; Carlos Torres-Cabala; Yuen-Li Chung; Maria Merino; Jane Trepel; Berton Zbar; Jorge Toro; Peter J Ratcliffe; W Marston Linehan; Len Neckers Journal: Cancer Cell Date: 2005-08 Impact factor: 31.743
Authors: M I Koukourakis; A Giatromanolaki; E Sivridis; G Bougioukas; V Didilis; K C Gatter; A L Harris Journal: Br J Cancer Date: 2003-09-01 Impact factor: 7.640
Authors: Nadine Fabienne Voelxen; Sebastian Blatt; Pascal Knopf; Maurice Henkel; Christina Appelhans; Leonardo A R Righesso; Andreas Pabst; Jutta Goldschmitt; Stefan Walenta; Andreas Neff; Wolfgang Mueller-Klieser; Thomas Ziebart Journal: Clin Oral Investig Date: 2017-07-22 Impact factor: 3.573
Authors: Richard A Burkhart; Danielle M Pineda; Saswati N Chand; Carmella Romeo; Eric R Londin; Edward D Karoly; Joseph A Cozzitorto; Isidore Rigoutsos; Charles J Yeo; Jonathan R Brody; Jordan M Winter Journal: RNA Biol Date: 2013-06-13 Impact factor: 4.652
Authors: Sebastian Blatt; Nadine Voelxen; Keyvan Sagheb; Andreas Max Pabst; Stefan Walenta; Thies Schroeder; Wolfgang Mueller-Klieser; Thomas Ziebart Journal: Clin Oral Investig Date: 2016-01-04 Impact factor: 3.573
Authors: Marco Johannes Battista; Kristina Goetze; Marcus Schmidt; Cristina Cotarelo; Veronika Weyer-Elberich; Annette Hasenburg; Wolfgang Mueller-Klieser; Stefan Walenta Journal: J Cancer Res Clin Oncol Date: 2016-06-24 Impact factor: 4.553
Authors: Melissa N Loja; Zhen Luo; D Greg Farwell; Quang C Luu; Paul J Donald; Deborah Amott; Anh Q Truong; Regina F Gandour-Edwards; N Nitin Journal: Int J Cancer Date: 2012-10-11 Impact factor: 7.396
Authors: Thomas Ziebart; Sebastian Blatt; Christian Günther; Nadine Völxen; Andreas Pabst; Keyvan Sagheb; Sebastian Kühl; Thomas Lambrecht Journal: Clin Oral Investig Date: 2016-03-19 Impact factor: 3.573